BC-CfE study examines how neighbourhood poverty affects those living with HIV

A recently published study by BC-CfE researchers titled Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort studyexamines the relationship between a neighbourhood’s socioeconomic status and how this affects the lives and health of Canadians living with HIV who are on combination antiretroviral therapy (ART).

Read More »

HIV cure research advanced with deeper knowledge of viremic controllers

There is currently no cure for HIV because the virus is able to persist in the body even during long-term antiretroviral therapy. BC-CfE scientists have published new research that characterizes in detail the HIV sequences that persist in the bodies of viremic controllers. Viremic controllers are a rare group of people whose immune systems naturally control HIV replication to low levels, but who nevertheless still benefit from antiretroviral therapy. This new research adds to the body of knowledge that is needed to develop an HIV cure.

Read More »

BC’s success story shows strength of Treatment as Prevention

On December 1st we celebrate World AIDS Day, an opportunity to reflect on our challenges and successes four decades into the battle against HIV/AIDS. Around the world there are nearly 38 million people living with HIV and about 1.5 million new infections per year. A recent report by the World Health Organization estimates the number of people with the virus being treated with antiretrovirals had risen to 27.5 million – an increase of almost 10% over the last year. Encouraging but not enough.

Read More »